Viewpoint

Alan Leshner, CEO of the American Association for the Advancement of Science, caused a stir at February’s EU ministerial conference in Copenhagen, with a hard-hitting speech on the state of US science. America's scientific eminence, 'is at risk' he said.

Hard-pressed healthcare systems can no longer pay premium prices for new drugs. The consequence will be less innovation in Europe says Andrew Witty, CEO of GlaxoSmithKline.

Only world-class science will deliver the innovation and growth Europe so desperately needs. US experience can help EU policy makers understand how to enhance R&D productivity and encourage excellence, says Paula Stephan

Governments can play a key role in triggering new models of collaboration, concludes the Science|Business Innovation Board

eHealth provides the means to reduce costs and improve the quality of our healthcare systems. It is now time for policy makers to take concrete measures to scale-up and accelerate adoption of technologies for real impact, says Elena Bonfiglioli

UK innovation strategy is changing, with a move away from across-the-board generic support, and a return to picking winners and promoting particular technologies

2012 has arrived with little prospect of economic revival. New start-ups must be better prepared than ever if they are to succeed

As China becomes a major generator of intellectual property, so it is becoming more committed to protecting IP and enforcing the law

A gathering of ‘innovation’ experts at an EU conference highlights the political importance of innovation. But what is it?

The European Commission has released its official proposal for Horizon 2020, the EU’s new research funding scheme. Science|Business presents a roundup of first reactions from the European capital.